ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

August 8, 1975

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

NCI-Approved CTEP Trials For the Month of October

October 26, 2012

In Brief: Clearinghouse Charter Renewed For Two Years; Good On China, Carbone On Communciation

May 26, 1978